Profile avatar
hmzacelik.bsky.social
Scientist interested in hematological malignancies. Associate Director, Incyte.
1 posts 176 followers 300 following
Regular Contributor
Posts 18 Comments 1

We are hiring 😀 Postdoctoral position – Stem cells, Cancer, and Aging We study cell fate decision and lineage specification in hematopoietic stem and multipotent progenitor populations to modulate lineage output for therapeutic purpose in diseases and aging contexts.

submitted 129 days ago • 1 comment

Delighted to share our #hematology review article on mutant calreticulin in #MPN Congrats to co-authors Drs. Mifra Faiz, Merle Riedemann & Jonas Jutzi. We hope it’s a useful resource, link below! @stanforddeptmed.bsky.social link.springer.com/article/10.1...

submitted 131 days ago • 0 comments

🎉 Happy New Year from #DrawImpacts Studio! 🎨 We’re thrilled to kick off 2025 with exciting news: our first cover of the year has been selected for #CellStemCell 's first issue of 2025!! To another year of impactful collaborations, science, and creativity—we can’t wait to see what this year brings! 🌟

submitted 138 days ago • 1 comment

A nice review in @bloodjournal.bsky.social of all things menin in AML! ashpublications.org/blood/articl...

submitted 144 days ago • 0 comments

Will definitely work with Emma👇

submitted 164 days ago • 1 comment

Hey all you #ASH24 people. You need to look at this new paper in @naturemethods.bsky.social by Heme extraordinaires Grant Rowe and the Bluesky-less #HojunLi. A paper that looks at Blood & Time from @bloodandtime.bsky.social himself! #scRNAseq #bioinformatics 🧬 💻 www.nature.com/articles/s41...

submitted 164 days ago • 1 comment

What does the circulating proteome teach us about common heart diseases? Thrilled to share our analysis identifying new biomarkers, drug targets, and prediction models for these conditions. Mentored (supremely) by @mchonig.bsky.social and @pnatarajanmd.bsky.social nature.com/articles/s44... (1/x)

submitted 181 days ago • 3 comments

Congrats to all involved in this study of a monoclonal antibody targeting mutant CALR in #MPN, first presented at #ASH23, this mAb is now in a phase 1 multicenter clinical trial, open at Stanford #Hematology @stanforddeptmed.bsky.social @bloodjournal.bsky.social ashpublications.org/blood/articl...

submitted 171 days ago • 0 comments

Congrats to Dr. Jason Gotlib on opening a JAK2V617F selective inhibitor trial at Stanford #Hematology in record time! This is a new class of #JAK2 inhibitor, phase 1 trial for patients with myelofibrosis & JAK2V617F is open & recruiting! @stanforddeptmed.bsky.social med.stanford.edu/cancer/about...

submitted 172 days ago • 0 comments

Excited for #ASH24 & thrilled that *3* brilliant folks from the team have oral presentations, travel awards and 2/3 nominated for **best of ASH**!! @imm.ox.ac.uk @ox.ac.uk @cancerresearchuk.org @ludwigcancer.bsky.social

submitted 172 days ago • 3 comments

very cool paper by @mpndoc.bsky.social et al looking at RSK1 as a therapeutic target in FLT3-ITD AML! www.nature.com/articles/s41...

submitted 173 days ago • 0 comments

Look who's here @pnas.org ✔️ @science.org ✔️ @naturecellbiology.bsky.social ✔️ @natrevgenet.bsky.social ✔️ @naturebiotech.bsky.social ✔️ @naturemicrobiol.bsky.social ✔️ @naturechemistry.bsky.social ✔️ @genesdev.bsky.social ✔️ @cellchembiol.bsky.social ✔️ @genomeresearch.bsky.social ✔️ @jcellbiol.bsky.social ✔️

submitted 177 days ago • 34 comments

Are neutrophils "good" or "bad"? Rana Herro reviews the current literature here: rdcu.be/d0Rt7

submitted 181 days ago • 2 comments

Hi, I’m Emma Vidal, founder of #DrawImpacts, a creative agency specializing in striking cover art for leading journals, scientific figures, logos, slides & web design tailored to the scientific community We’re new here and excited to connect! Let’s make an impact together!✨🚀 #SciArt drawimpacts.com

submitted 182 days ago • 4 comments

Download our database of 492 (!) funding opportunities for EARLY-CAREER FACULTY AND RESEARCHERS. For each entry, we provide link to funder, description, amount, deadline, and eligibility criteria (e.g. citizenship). Download freely here: research.jhu.edu/rdt/funding-...

submitted 184 days ago • 12 comments

First manuscript from Linde Miles Lab at CCHMC looking at clonal evolution in NPM1-mut AML at single cell resolution. Check out the pre-print here: www.biorxiv.org/content/10.1...

submitted 184 days ago • 2 comments

Finally- the starter pack we have all been waiting for is here … Hematopoiesis 🎉❤️🩸🦴 So excited to have reached a critical mass of this community on here. 🙌🏻 Let me know if you want to be added!! go.bsky.app/KWdX5w7

submitted 185 days ago • 39 comments

It’s always a great start to the day to learn we have one more drug to offer patients with r/r leukemia! 🎗️🩸💊 www.fda.gov/drugs/resour...

submitted 185 days ago • 1 comment